Latest early breast cancer Stories
A team of UK researchers led by Oxford University scientists has devised a new test that could help doctors diagnose breast cancer earlier by detecting changes in a person’s zinc levels.
Initial Investment Enables Filing of FDA Class II 510k Now Underway for Pioneer in Early Breast Cancer Detection Reno, NV (PRWEB) April 16, 2014 First
Popular TV and Blog Healthcare Expert Joins Pioneer in Early Breast Cancer Detection Reno, Nev. (PRWEB) March 18, 2014 First Warning Systems, Inc.
For the first time, researchers have estimated the daily dose of radiotherapy that could be wasted in compensating for cancer cell growth that occurs overnight and during weekends in patients with early breast cancer.
Detecting the presence of circulating tumor cells (CTCs) in the blood of women with early breast cancer after surgery but before the start of chemotherapy can provide useful information about their chances of surviving the disease.
Results from the longest-running trial comparing tamoxifen with the aromatase inhibitor letrozole show unequivocally that letrozole has withstood the test of time and continues to prevent breast cancer recurrences and reduce the risk of death in post-menopausal women with hormone receptor-positive early breast cancer.
A major UK trial has produced firm evidence that giving radiotherapy between or during chemotherapy cycles to women with early breast cancer significantly reduces the risk of the cancer recurring in the breast or chest wall.
A global study of nearly 10,000 women with early breast cancer has found wide variations in how they were treated, despite international consensus on best practice, according to the May issue of the British Journal of Surgery.